[ASAP] Assessing the Manufacturability and Critical Quality Attribute Profiles of Anti-IL-8 Immunoglobulin G Mutant Variants 🔗 Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c01010 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
